Fundamental Data for DCGN

DECODE GEN(NSDQ:DCGN)

DECODE GENETICS is a genomics and health informatics company which applies and develops modern informatics to collect and analyze data about the Icelandic population in order to develop products and services for the healthcare industry.

# Employees: 331

Address: Sturlugata 8,Reykjavik,,ISL

Phone: 354 570-1900

Fax: 354 570-1903

Website: www.decode.com

Email: ir@decode.is

Sector: Medical

Industry: MED-BIOMED/GENE

Executive Officers

Kari Stefansson (Chmn.; Presi.; C.E.O.; Dir.)

Lance Thibault (C.F.O.; Treas.; Princ. Acctg. Off.)

Terrance Mcguire (Dir.)

Neal J. Armstrong (Dir.)

James Beery (Dir.,)

Dividend

Ex-Dividend Date: N/A

Annual Dividend: N/A

Current Dividend Yield: N/A

Dividend Paid (3 months): N/A

Indicated Dividend: N/A

Earnings

Last Earnings Date: 6/30/2009

Next Earnings Date(Expected): 11/20/2009

Mean EPS (Next Qtr): ($0.01)

Mean EPS (Year): ($0.01)

Mean Estimate(Long Term): ($0.01)

P/E Ratio(Based on EPS estimate): -0.010

Number of Estimates: 0

Shares Performance

Period	DCGN	Compare to S&P
YTD	-76.76 %	-80.76 %
4 Weeks	-85.90 %	-86.05 %
12 Weeks	-92.18 %	-92.63 %

Shares Information

Analyst Coverage: N

Avg Volume: 2756874

Shares Outstanding: 61M

Market Cap: $0.00B

52 Week High: $0.77

52 Week Low: $0.03

P/E Ratio: -0.010

PEG Ratio: -0.010

Split: On 1/1/1990 DCGN split by factor of 0.050

Earnings Performance

EPS Growth in Last Quarter: 4.76 %

EPS Growth in Last Year: 33.33 %

Sales Growth in Last Quarter: -60.74 %

Sales Growth in Last Quarter: -76.70 %

Financials

Qtr Book Value: ($0.01)

Cash Flow/Share: ($0.01)

Change in Payout Ratio: -0.010

Price/Sales: -0.010